DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 1 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $1,099,937 | -3.3% | 69,926 | -0.9% | 0.02% | -4.3% |
| Q4 2023 | $1,137,586 | +26.8% | 70,526 | +0.0% | 0.02% | +21.1% |
| Q3 2023 | $897,028 | -13.5% | 70,521 | -4.3% | 0.02% | -5.0% |
| Q2 2023 | $1,037,485 | +17.7% | 73,685 | +29.2% | 0.02% | +17.6% |
| Q1 2023 | $881,361 | -5.7% | 57,046 | +0.0% | 0.02% | -5.6% |
| Q4 2022 | $934,526 | +74.4% | 57,018 | +96.9% | 0.02% | +63.6% |
| Q3 2022 | $536,000 | +3.9% | 28,959 | -26.1% | 0.01% | +22.2% |
| Q2 2022 | $516,000 | +8.9% | 39,168 | -23.3% | 0.01% | +28.6% |
| Q1 2022 | $474,000 | +35.8% | 51,060 | +43.2% | 0.01% | +75.0% |
| Q4 2021 | $349,000 | +73.6% | 35,656 | +503.6% | 0.00% | +33.3% |
| Q3 2021 | $201,000 | -7.4% | 5,907 | +0.1% | 0.00% | +50.0% |
| Q2 2021 | $217,000 | – | 5,904 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DekaBank Deutsche Girozentrale | 50,000 | $759 | 0.00% |